| Pharmaceutical active ingredients: |
| Maraviroc |
| Available forms, composition and doses of Selzentry: |
| Tablets; Oral; Maraviroc 150 mgTablets; Oral; Maraviroc 300 mg |
| Selzentry medical category: |
| Human:HIV fusion inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AX09 - Maraviroc |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerViiV Healthcare |
| Related documents and information about Selzentry: |
| Selzentry prescribing information (PDF) |